SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 113 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $453,000 | +387.1% | 150,400 | +295.2% | 0.00% | – |
| Q1 2015 | $93,000 | -64.6% | 38,056 | -63.1% | 0.00% | -100.0% |
| Q4 2014 | $263,000 | -61.4% | 103,112 | +8.0% | 0.00% | -66.7% |
| Q3 2014 | $682,000 | +176.1% | 95,462 | +152.2% | 0.00% | +200.0% |
| Q2 2014 | $247,000 | +41.1% | 37,850 | +42.8% | 0.00% | 0.0% |
| Q1 2014 | $175,000 | +48.3% | 26,500 | +6.4% | 0.00% | – |
| Q4 2013 | $118,000 | -7.1% | 24,899 | -3.0% | 0.00% | -100.0% |
| Q3 2013 | $127,000 | +4.1% | 25,659 | +10.0% | 0.00% | 0.0% |
| Q2 2013 | $122,000 | – | 23,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
| GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
| Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
| Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
| ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
| HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
| Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
| Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |